MAPT and Alzheimer disease: We included phosphorylated tau 181 (P-tau181), amyloid beta (Aβ) 42/40 ratio, P-tau181/Aβ42 ratio, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) as AD-related biomarkers.